Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADV7103 in cystinuria
NCT04147871Phase 3Withdrawn
- Sponsor
- Advicenne
- Start
- Mar 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Sibnayal in cystinuria (CSNU), sponsored by Advicenne. Planned start Mar 2024; status: withdrawn.
02
Drugs
Sibnayal
03
Conditions
cystinuria (CSNU)
Beyond the preview
Go deeper on NCT04147871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147871.